Literature DB >> 20302589

Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year follow-up.

Fernando M Silva1, Tomas Navarro-Rodriguez, Ricardo C Barbuti, Rejane Mattar, Claudio L Hashimoto, Jaime N Eisig.   

Abstract

BACKGROUND: The Helicobacter pylori reinfection seems to be higher in developing countries, than in developed ones. The aim of the study was to determine the annual recurrence rate of H. pylori, in Brazilian patients with peptic ulcer disease, in a 5-year follow-up.
METHODS: Patients, with peptic ulcer disease diagnosed by upper digestive endoscopy (UDE) and H. pylori infection verified by histological analysis, rapid urease test, polymerase chain reaction, and urea breath test (UBT), were treated for bacterial eradication. The cure of the infection was verified using the same tests, 3 months after. Clinical evaluation and UBT were performed after sixth and ninth month. After 1 year of follow-up, UBT and UDE were repeated. Up to the fifth year, patients were assessed twice a year and an UBT was performed annually. The patients included and all the reinfected were tested for 15 different genes of the H. pylori.
RESULTS: One hundred and forty-seven patients were followed: 19 for 1 year, eight for 2 years, four for 3 years, five for 4 years, and 98 for 5 years, totaling 557 patients/years. Recurrence did not occur in the first year. In the second year, two patients were reinfected; in the third, four patients; in the fourth, three patients; and in the fifth, one patient. The total of reinfected patients was 10. The annual reinfection rate was 1.8%.
CONCLUSION: Brazil presents a low prevalence of H. pylori reinfection, similar to the developed countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20302589     DOI: 10.1111/j.1523-5378.2009.00734.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  13 in total

1.  Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Authors:  Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients.

Authors:  Laimas Jonaitis; Gediminas Kiudelis; Paulius Slepavicius; Limas Kupcinskas
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.

Authors:  Theodora Choli-Papadopoulou; Filippos Kottakis; Georgios Papadopoulos; Stefanos Pendas
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 4.  Optimal therapy for Helicobacter pylori infections.

Authors:  Emiko Rimbara; Lori A Fischbach; David Y Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

5.  Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.

Authors:  Douglas R Morgan; Javier Torres; Rachael Sexton; Rolando Herrero; Eduardo Salazar-Martínez; E Robert Greenberg; Luis Eduardo Bravo; Ricardo L Dominguez; Catterina Ferreccio; Eduardo C Lazcano-Ponce; Maria Mercedes Meza-Montenegro; Edgar M Peña; Rodolfo Peña; Pelayo Correa; María Elena Martínez; William D Chey; Manuel Valdivieso; Garnet L Anderson; Gary E Goodman; John J Crowley; Laurence H Baker
Journal:  JAMA       Date:  2013-02-13       Impact factor: 56.272

6.  Follow-up of Helicobacter pylori infection in children over two decades (1988-2007): persistence, relapse and acquisition rates.

Authors:  J Vanderpas; P Bontems; V Y Miendje Deyi; S Cadranel
Journal:  Epidemiol Infect       Date:  2013-06-28       Impact factor: 4.434

7.  Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers.

Authors:  Fernando Marcuz Silva; Elaine Cristina Silveira de Queiroz; Tomás Navarro-Rodriguez; Ricardo Correa Barbuti; Rejane Mattar; Kiyoshi Iriya; Jin Hwa Lee; Jaime Natan Eisig
Journal:  Clinics (Sao Paulo)       Date:  2015-05-01       Impact factor: 2.365

Review 8.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

9.  Helicobacter pylori incidence and re-infection in the Aklavik H. pylori Project.

Authors:  Sally Carraher; Hsiu-Ju Chang; Rachel Munday; Karen J Goodman
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

10.  Endoscopic findings in uninvestigated dyspepsia.

Authors:  Jacob Jehuda Faintuch; Fernando Marcuz Silva; Tomás Navarro-Rodriguez; Ricardo Correa Barbuti; Claudio Lyoiti Hashimoto; Alessandra Rita Asayama Lopes Rossini; Marcio Augusto Diniz; Jaime Natan Eisig
Journal:  BMC Gastroenterol       Date:  2014-02-06       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.